Intramuscular delivery of a naked DNA plasmid encoding proinsulin and pancreatic regenerating III protein ameliorates type 1 diabetes mellitus
- 1 April 2011
- journal article
- Published by Elsevier in Pharmacological Research
- Vol. 63 (4) , 320-327
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Proteomic analysis of mouse islets after multiple low-dose streptozotocin injectionBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2007
- Moving towards efficient therapies in type 1 diabetes: To combine or not to combine?Autoimmunity Reviews, 2007
- Intravascular insulin gene delivery as potential therapeutic intervention in diabetes mellitusBiochemical and Biophysical Research Communications, 2003
- Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapyProceedings of the National Academy of Sciences, 2002
- Adenoviral vector-mediated insulin gene transfer in the mouse pancreas corrects streptozotocin-induced hyperglycemiaGene Therapy, 2001
- Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive RegimenNew England Journal of Medicine, 2000
- Multiple low-dose and single high-dose treatments with streptozotocin do not generate nitric oxideJournal of Cellular Biochemistry, 2000
- American Diabetes Association Annual Meeting, 1999. New approaches to insulin treatment and glucose monitoring.Diabetes Care, 1999
- Type I Diabetes MellitusNew England Journal of Medicine, 1986
- Complete protection from low-dose streptozotocin-induced diabetes in miceNature, 1978